Global Cord Blood Corp Stock Nyse
Equities
KYG211071009
Healthcare Facilities & Services
Sales 2021 | 1.16B 161M 219M | Sales 2022 | 1.24B 172M 235M | Capitalization | 2.97B 411M 560M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.34M 95.88M | Net income 2022 | 501M 69.37M 94.56M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 841M 1.15B | Net cash position 2022 | 6.66B 922M 1.26B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
1st Jan change | Capi. | |
---|---|---|
-29.22% | 70.3B | |
+2.04% | 27.46B | |
-6.85% | 17.8B | |
+2.24% | 17.46B | |
+1.77% | 15.46B | |
+6.75% | 13.49B | |
+10.46% | 13.06B | |
+70.48% | 12.96B | |
+74.20% | 12.56B |